Bioheart Appoints Advisory Board of Business and Financial Executives

Greenberg Traurig Law Firm Named SEC Counsel SUNRISE, Fla., Feb. 29, 2012 (GLOBE NEWSWIRE) -- Bioheart, Inc. (OTCBB:BHRT) announced today it has appointed a five-member Advisory Board comprised of local and international business, financial and marketing executives to assist in the development of the company's new business plan. In addition, Corporate & Securities attorney David E. Wells, a Shareholder with the law firm of Greenberg Traurig has been engaged by Bioheart as SEC counsel. "The...continued BHRT  Drugs Healthcare

URL: http://www.investorpoint.com/news/INVESTOP/48894404/